Flow cytometry analysis of platelet cyclooxygenase-2 expression: Induction of platelet cyclooxygenase-2 in patients undergoing coronary artery bypass grafting

British Journal of Haematology

Volumn 117, Issue 2, 2002, Pages 424-426

  Weber, Artur Aron ^a   Przytulski, Boris ^a   Schumacher, Marc ^a   Zimmermann, Norbert ^a   Gams, Emmeran ^a   Hohlfeld, Thomas ^a   Schrör, Karsten ^a,b  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Coronary artery bypass surgery; Cyclooxygenase 1; Cyclooxygenase 2; Flow cytometry; Platelets

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ENZYME ANALYSIS; ENZYME INDUCTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ASPIRIN; BLOOD PLATELETS; CORONARY ARTERY BYPASS; CORONARY DISEASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TIME FACTORS;

EID: 0036252408     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03423.x     Document Type: Article

References (12)

1. Platelet CD40 ligand (CD40L): Subcellular localization, regulation of expression, and inhibition by clopidogrel
2. Aspirin resistance coincides with platelet COX-2 expression but not with enhanced aspirin esterase activity
3. Differential expression of thromboxane A synthase and prostaglandin H synthase in megakaryocytic cell line
4. COX-2 is not involved in thromboxane biosynthesis by activated human platelets
5. Aspirin as an antiplatelet drug
6. Platelet-active drugs. The relationships among dose, effectiveness, and side effects
7. Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets
8. Cyclooxygenases 1 and 2
9. Differential inhibition of adenosine diphosphate- versus thrombin receptor-activating peptide-stimulated platelet fibrinogen binding by abciximab due to different GPIIb/IIIa activation kinetics
10. Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance
11. 2 metabolism and results in an altered susceptibility to aspirin effects
12. Aspirin resistance after coronary artery bypass grafting